Morote, J.; Borque-Fernando, Á.; Esteban, L.M.; Celma, A.; Campistol, M.; Miró, B.; Méndez, O.; Trilla, E.
Investigating Efficient Risk-Stratified Pathways for the Early Detection of Clinically Significant Prostate Cancer. J. Pers. Med. 2024, 14, 130.
https://doi.org/10.3390/jpm14020130
AMA Style
Morote J, Borque-Fernando Á, Esteban LM, Celma A, Campistol M, Miró B, Méndez O, Trilla E.
Investigating Efficient Risk-Stratified Pathways for the Early Detection of Clinically Significant Prostate Cancer. Journal of Personalized Medicine. 2024; 14(2):130.
https://doi.org/10.3390/jpm14020130
Chicago/Turabian Style
Morote, Juan, Ángel Borque-Fernando, Luis M. Esteban, Ana Celma, Miriam Campistol, Berta Miró, Olga Méndez, and Enrique Trilla.
2024. "Investigating Efficient Risk-Stratified Pathways for the Early Detection of Clinically Significant Prostate Cancer" Journal of Personalized Medicine 14, no. 2: 130.
https://doi.org/10.3390/jpm14020130
APA Style
Morote, J., Borque-Fernando, Á., Esteban, L. M., Celma, A., Campistol, M., Miró, B., Méndez, O., & Trilla, E.
(2024). Investigating Efficient Risk-Stratified Pathways for the Early Detection of Clinically Significant Prostate Cancer. Journal of Personalized Medicine, 14(2), 130.
https://doi.org/10.3390/jpm14020130